Our guest this week is Paul Nioi, Senior Vice President of Research at Alnylam and we talked about the evolution of RNAi. The post How RNAi is expanding from a therapy of choice for rare disease into treating common conditions appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that ful...
